CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Adalvo against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Glp-1 Compositions And Uses ThereofNOVO NORDISKNov 7, 2024
Methods Of Treating Or Preventing Spinal Muscular AtrophyBIOGEN MAAug 22, 2024
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024
Tablets Comprising Tamsulosin And SolifenacinSYNTHONJan 23, 2024
Ribociclib TabletNOVARTISAug 15, 2023
Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIMJun 13, 2023
Semaglutide In Cardiovascular ConditionsNOVO NORDISKMay 9, 2023
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAApr 14, 2023
Pharmaceutical Composition Comprising Drospirenone And Contraceptive KitLABORATORIOS LEON FARMAOct 12, 2022
Liraglutide In Cardiovascular ConditionsNOVO NORDISKMay 3, 2022

Explore Adalvo's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 27, 2022Oral Solutions Comprising Lisdexamfetamine Salts1

Top competitors of Adalvo

List of top competitors of Adalvo based on patent oppositions.